bq 610 has been researched along with phosphocreatine in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 7,475 | 329 | 575 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bureik, P; Ertl, G; Hahn, S; Han, H; Horn, M; Illing, B; Neubauer, S | 1 |
1 other study(ies) available for bq 610 and phosphocreatine
| Article | Year |
|---|---|
Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Coronary Circulation; Endothelins; Energy Metabolism; Heart; Heart Rate; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oligopeptides; Phosphocreatine; Rats; Rats, Wistar; Ventricular Pressure | 1996 |